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by Steven R. Tannenbaum,' Paul L. Skipper,'
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Analysisofthetypesofproteinadducts formedbychemicalcarcinogensindicate that adductsmay becategorized in-
tovariousclassesaccordingtothenatureofthecarcinogenasweDlastheaminoacidwithwhichtheyreact.Tryptophan(214)
ofserum albumin was previously shown toreact specifically withN-sulfonyloxy-N-acetyl-4-aminobiphenyl. The same
residueisnowshowntoalsoreactwiththesulfateestersofN-hydroxy-N-acetyl-2-aminofluorene andN-hydroxy-N,N' -
diacetylbenzidine. Thus, Trp-214appearstobeabindingsiteforavariety ofactivated N-aryl hydroxam;ic acids. Epox-
idesanddiolepoxides derived from polynucleararomatichydrocarbonsalkylatecarboxylicgroupsinhemoglobin and
serumalbumin. Becausetheestersformedarereadilyhydrolydtodihydrodiolsandtetrahydrtetrls whichcanbedeter-
mined by GC-MS, it is possible toanalyzeforawide rangeofpolyaromatic hydrocarbon (PAH) epoxideadducts. With
thisapproachitwasshownthathumansubjectsexperiencingexposuretoambientlevelsofenvironmental PAH dotake
upandmetabolizechryseneandbenzolalpyrene. Feral,bottom-dwelling fishinhabitingcontaminatedwaterswerealso
examined. Globinadductscontainingcertaindihydroxy groupssuch asthosearising inanli-diol epoxide adducts were
concentrated byboronateaffinity chromatography and furtheranalyzed byHPLC with diode-array UV/visible detec-
tion. Fourcompounds weredetectedthatexhibitedspectracharacteristic ofapolynuclearchromophore. Twaoftheseap-
peared to beisomers. Further instrumental analysis is needed toelucidate the structureofthese unknownputative ad-
ducts. A discussion ofhowtheseanalyses might beconductedaswell astheirextension tolessheavily adducted human
globin samples is presented.
Introduction
Carcinogens or their electrophilic metabolites interact with
proteins [recently reviewed in SkipperandTannenbaum(1)] as
well as DNA. It has been shown that the amount of a protein-
carcinogenadductformed maybeused as aquantitative measure
ofexposure tothecarcinogen. Theprecisionofthismethodwill
vary fordifferentcarcinogensdepending ontheextentofinterin-
dividual differences inuptakeanddisposition. Similarly, protein
adductlevelshavealsobeenshown toreflectgeneticdamage, and
it may beassumed thatthedegree ofcorrelationbetween adducts
and genetic damage will alsodepend on the extent to which in-
terindividual differences contribute tothedisposition ofthe com-
pound. Becausethey are morereadilyobtainable than DNAad-
ducts, protein adducts have an important role in both exposure
assessment and genotoxic effects assessment.
Two proteins, hemoglobin and serum albumin, have so far
been the nearly exclusive focus of research efforts both in
chemistry andepidemiology. Hemoglobin wasthefirstprotein
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proposed for the purpose of molecular dosimetry (2), and
numerous subsequentstudieshaveborneoutitsutility. Human
exposures to ethylene oxide (3), aromatic amines (4), ben-
zo[a]pyrene (BaP) (5), and the tobacco-specific nitrosamines
NNNandNNK(6)cannowbedeterminedroutinely. Ithaseven
beenpossibleinthecaseof4-aminobiphenyl todemonstratethe
influenceonadductlevelsofametabolicphenotypeknowntobe
a risk factor (7). Serum albumin has also proven to be a good
targetproteinfordosimetry inhumanpopulations, particularly
foraflatoxinB1 (8,9). Serumalbuminadductsmayalsoproveto
be useful for the dosimetry ofthe food pyrolysis heterocyclic
aminesbecausethesecompoundsmayhavethesamesulfinamide
structure asthehemoglobin-aromatic amine adducts (10).
Theanalytical methodsdevelopedforthesestudiestendtobe
highly specificforacompoundoranarrowclassofcompounds.
Ethylene andpropyleneoxides formN-hydroxyethylvaline and
N-hydroxypropylvaline, respectively, which are selectively
cleavedby amodifiedEdmandegradation (11). Aromaticamine
sulfinamide adducts are cleaved by base-catalyzed hydrolysis,
andtheproductaminesareseparatedbysolventextraction. NNN
and NNK adducts also undergo base-catalyzed hydrolysis,
releasing 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB), but the
subsequent isolation procedure is quite different (6). Ben-
zo[a]pyrene diol epoxide adducts are cleaved by spontaneous
hydrolysis facilitatedbyenzymaticproteolysis, andtheproductTANNENBAUMETAL.
tetrahydrotetrols areisolatedbymonoclonalantibody immunoaf-
finity chromatography (12). Aflatoxin adducts areisolated as a
modified lysine residue fromthoroughly proteolyzed albuminby
immunoaffinity chromatography (8,9).
Inthispaperweexplorethepossibility thatcertainprocedures
developed for specific adducts canbegeneralized topermitthe
detectionofadditional similarbutundetermined adducts. Recent
resultsobtained inourlaboratories aredescribed, andweattempt
toelucidate someofthe forcesgoverningthe interaction ofcar-
cinogens withproteins inanefforttoindicatedirectionsforfuture
research.
Protein Binding Sites
The binding ofa ligand by its protein receptor is commonly
thought tobeahighly specific interaction, as isantibody-antigen
binding. Insuchcases, itisoftenpossibletodescribethebinding
siteinquite specific termswith respecttothefunctional groups
that interactwith theligandandtheirspatialorientation, aswell
as other dimensional features. As applied to the interaction of
proteins withcarcinogens, the conceptofbinding siteshasbeen
drawn more loosely. Three related butdistinct definitions may
bemade, which will formthebasis forthediscussion tofollow.
First, because the formation ofacarcinogen-protein adduct
involves the formation of a covalent bond to an amino acid
residue intheprotein, itmaybeusefultothinkofthebinding site
as the specific residue that undergoes reaction. A second ap-
proach is to define a binding site as any one ofthe 10 different
functional groups (hydroxyl, amine, thiol, thioether, carboxyl,
carboxamide, guanidine, imidazole, phenol, orindole) foundon
aminoacid sidechains, irrespectiveofitslocationinthepolypep-
tidechain. Third, abinding sitemaybedescribed asaregionof
theprotein without reference toany specific residue. As wewill
show, eachofthesedefinitions hasdifferent ramifications forthe
developmentofmethods to detect andidentify newcarcinogen
adducts.
The Binding Site As a Specific
Amino Acid Residue
Specific Cases. Severalexamplesofcarcinogenbinding sites
defined asaspecific residuearenowknown. TheNH2-terminal
valine ofhemoglobin is perhaps the best example. The amino
groupofthisvalinehasbeenshowntoreactwithavarietyofalkyl-
atingagentsproducinginteraliaN-methyl,N-ethyl,N-hydroxy-
ethyl,N-hydroxypropyl, andN-hydroxyphenylethyl valines(11).
Moreover,aldehydeswillcondensewiththeNH2-terminal valine
aminogroup. Aprototypicalexampleisthereaction ofglucose
with hemoglobin, and, although glucose is not a carcinogen,
otheraldehydes with potential genotoxic activity such as malon-
dialdehyde also will reactwithhemoglobin inthe sameway (12).
IthasbeenparticularlyusefultoconceiveoftheNH2-terminal
aminogroupas abindingsite. By sodoing, ageneralized method
foradduct separation andpurificationbecameapparent sincethe
peptidebondinpolypeptides canbesequentiallycleavedthrough
the Edmanprocedure. Furtheradductconcentrationwasthenac-
complished by modification of the Edman procedure, which
made itmoreselective forthealkylated formofvaline, thereby
reducing theamount ofnonalkylated valine accompanying the
adducts.
Anotherspecific aminoacidthathasbeen showntoparticipate
inreaction withanumberofcarcinogens isthecysteine(93fl) of
hemoglobin. Fourteenaromaticamineshavebeenidentifiedas
having reacted with human hemoglobin in vivo (4), and,
althoughtheexactstructurehasonlybeendeterminedinonecase
(14) anddeduced from circumstantial evidence in another (15),
it is almost certain, considering the chemistry ofthe aromatic
amine-hemoglobin interaction, thattheother 12 adductshavethe
samestructure. Alltheamineadductsdetectedthusfarhavebeen
formedbymonocyclicorbicyclicamines. Evidenceislackingfor
the presence of larger aromatic amine adducts in human
hemoglobin.
Theknownaromatic amineadductsattheCys-93f canall be
determined by a common procedure. It is probably safe to
generalize and say that many other aromatic amine exposures
could be detected by application ofthe same procedure. Once
again, thereasonthataparticularprocedurecanbeextendedto
the analysis ofother adducts is that the procedure used cleaves
abondlinkingtheadduct,asmallmolecule, totheprotein, which
is amacromolecule. Thisprinciple finds application repeated-
ly; other examples will be describedbelow.
Thesingletryptophanresidueofserumalbuminisalsoabind-
ing site for a specific class of carcinogens. It was previously
reported that this amino acid reacts in vivo in the rat with a
metabolite of 4-aminobiphenyl, N-sulfonyloxy-N-acetyl-
4-aminobiphenyl (AABP), to form an adduct with a stable
tryptophan-aminobiphenyl linkage (16). We have now shown
that the same adduct is formed by reaction ofsynthetic sulfate
esterofN-hydroxy-AABPwith human serum albumin in vitro.
The essential roleofsulfation was demonstrated through addi-
tional in vitroexperimentswithhepatocytepreparations. Coin-
cubationofrathepatocytes with human serum albumin andN-
hydroxy-AABPgeneratedthetryptophan adduct, andtheyield
was greatly decreased by the omission of sulfate from the
medium or by the inclusion of the sulfotransferase inhibitor
dichloronitrophenol.
Likewise, it has been shown that the serum albumin tryp-
tophan reacts with the sulfate esters ofN-hydroxy-N-acetyl-2-
aminofluorene (AAF) and N-hydroxy-N,N' diacetylbenzidine
(dAB,) (F. F. Kadlubar, personal communication). Pronase
digestsofserumalbuminreactedwiththesyntheticsulfateesters
producedonemajorHPLCpeakineachcasewith retentiontime
similartothatoftheAABPadductpeak. The sameadductpeaks
wereproduced whenthehydroxamic acids were incubated with
hepatocytes and serum albumin, and their yield could be con-
trolledby theamountofsulfateand sulfotransferase inhibitors in
the medium.
Fast-atom bombardment (FAB)-MS was used for structure
determination. Pronase digestion yielded a tetrapeptide from
AABP-adducted serum albumin withthe sequenceAla-Trp-Ala-
Val. An intense (M+H) + ion (m/z 655) was observed in the
mass spectrum of this adduct corresponding to the peptidyl
residue (444) plus anacetylaminobiphenylyl group(210). Other
ions that resulted from various peptide chain fragmentations
were also observed, andthese ions were helpful inconfirming
the structureassignment.
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When the Pronase fragments corresponding to AAFanddABz
adducts were subjected to FAB-MS, (M+H)+ ions were
observed at m/z 667 andm/z 712, respectively, which correspond
to adducts of Ala-Trp-Ala-Val. As with the AABP adduct, ap-
propriate fragment ions were also observed.
These data suggest that nitrenium ions generated from
aromatic hydroxamic acids exhibit ahighdegree ofselectivity for
the tryptophan residue in human serum albumin. Modeling of
theprotein also suggests thatthere maybe significant sizeand/or
shape constraints on the structure ofthe hydroxamic acids. These
two properties may combine to define a quite selective binding
site.
QualitativeAnalysis ofAdditionalAdducts. Identification of
a specific residue as participating in reaction with carcinogens
may provide thebasis fordesigning approaches to the identifica-
tion of other adducts, as illustrated in the following example
drawn from research in K. Biemann's laboratories. Cysteine
(93,B) of hemoglobin reacts with certain electrophilic species
known as Michael acceptors to form stableproducts. Acrylamide
(17) and2-vinylpyridine are twogoodexamples. Themolecular
weight, at least, ofother adducts could be determined through
the following generic approach.
Cysteine(930)-adducted hemoglobin can be separated from
native hemoglobin chromatographically (18). Trypsinolysis
leads to the production ofa peptide containing the 93,B residue
(83-95), which can easily be separated from the other tryptic
fragments. Theadducted tryptic fragments are then introduced
into a tandem mass spectrometer for analysis. By monitoring
MS-2 for fragment ions characteristic ofthetryptic fragment and
stepping MS-1 through a range of mass values appropriately
greater thanthetryptic fragment, it ispossible to determine the
molecular weights ofadducted tryptic fragments.
Clearly, additional information would be needed to fully
elucidate structure. Nonetheless, the feasibility ofthis important
first stephasbeendemonstrated. Other spectroscopic techniques
for obtaining further structural information are available and
underdevelopment. Oneofthese, fluorescence line narrowing,
is described in more detail below.
The Binding Site As an Amino Acid
Functional Group
Identifying the specific amino acid residue that has reacted
with acarcinogen, ifindeed itis onlyone, isusually achalleng-
ingtask, especially iftheadductis formedbyanunstablelinkage.
Moreover, from apractical pointofview this identification may
be unnecessary. Thus, in many instances it may be worthwhile
tothinkofaproteinbindingsite forcarcinogens asjustoneofthe
ten different amino acid side chain functional groups without
reference to its location or locations in the protein.
Specific Cases. Theearliest studiesofprotein adductforma-
tion inwhich strong acid hydrolysis wasused todegradethepro-
tein took thisapproach. Alkylating agents were shown to form
N'- andN3-alkyl histidines, forexample, in addition to S-alkyl
cysteine. These adducts could be identified because they
possessed avery stablecarcinogen-amino acidlinkagethatsur-
vived the strong conditions ofhydrolysis used to isolate them.
Morerecently, ithasbecomeapparentthatmanycarcinogens
formless stablebondstotheaminoacidswithwhichthey react.
Nevertheless, the adducts may be stable in vivo as the result of
secondary interactions such as van der Waals attraction between
the carcinogen and other residues in theprotein. When adducted
protein is degraded by denaturation orproteolysis, these secon-
dary interactions are disrupted and the covalent adduct linkage
becomes susceptible to hydrolysis.
BPDE (r-7,t-8-dihydroxy-c-9,c-10-epoxy-7,8,9,10-tetrahydro-
benzo[a]pyrene), for example, reacts with human hemoglobin
mainly by alkylation of aspartate(47) in the a chain (19). The
product is stable innativehemoglobin, butonly dissociation into
dimers is necessary to initiate hydrolysis of the product ester.
Prooffor an ester adduct as the source ofBaP tetrol from pro-
teolysis of BPDE-treated hemoglobin was obtained through
isotope incorporation studies (20). The same approach was used
to demonstrate that BPDE alkylation ofhuman serum albumin
also yielded a substantial fraction ofester products (21). BPDE
appears to be typical ofthe benzylic epoxide metabolites ofthe
PAH class ofcarcinogens. Although the identity of the acidic
amino acids thatare alkylated by the PAH epoxides has notbeen
determined except in the case ofBPDE and hemoglobin, it ap-
pears that esters are acommon productand that they decompose
to give PAH alcohols upon proteolysis ofadducted proteins.
The PAH-derived esters hydrolyze so readily becausethe car-
bon atom that alkylates a carboxyl group is attached to an
aromatic ring system. When esters with such a structure are
hydrolyzed at neutral pH, the carboxyl group becomes a leaving
group. Its departure is greatly facilitated by delocalization ofthe
resultant carbonium ion throughout the aromatic rings. Because
even a single 6-membered ring is sufficient to effect this mode
ofcleavage (e.g., 1-phenylethyl esters), it is generally to be ex-
pected that PAH epoxides will form esters that spontaneously
hydrolyze.
We havetaken advantage ofthis generality to detect adducts of
PAH other than BaP in various types ofblood specimens. The
challenge hasbeen todevise methods for separatingthe resultant
PAH alcohols from the amino acid and peptide milieu generated
by proteolysis. One successful procedure has been monoclonal
antibody immunoaffinity chromatography. With this technique
it has been possible to demonstrate the presence ofadducts of
chrysene diol epoxide in human hemoglobin specimens (22).
Tentative evidence forthepresenceofseveral otherdiol epoxide
adducts has also been obtained (23). Equally important is the
absenceoftetrols thatareknowntocross-react withtheantibody
used, fortheir absencemay betakenasameaningful indication
that, although the individuals examined were exposed to the
parenthydrocarbonas aresultofitspresence intheenvironment,
thehydrocarbon was notmetabolized to adiol epoxide. Tetrols
that are conspicuously absent include the 7,8,9,10 tetrols
originating from the syn isomer ofBPDE as well as any tetrols
originating from benz[a]anthracene diol epoxides.
Another separation scheme that has been used is affinity
chromatography with boronate media. This approach is selec-
tive for, among others, 1,2-diols, which, ifin a ring, are cis to
each other. Such vicinal diols are present in those tetrols that
arise fromanti-diol epoxides. Boronateaffinity chromatography
hasbeenappliedtodigestsofglobinisolated fromferal, bottom-
dwelling fishthatliveincontaminatedwaters. HPLC analysisof
boronate-bound fractions are remarkably uncomplicated, as il-
lustrated in Figure 1.
53TANNEN4BAUMETAL.
A 343,4 550,100 of WFBS3*3.D
S
0
U)
100.
800
60.
40
20
LC B 300,4 550,100
10 20
Time (min.)
of WFBS3*3.D
4-
30
FIGURE 1. HPLC analysis ofboronate-bound fraction fromwinter flounder
globin. Sample wasprepared betreatmentofhemoglobinwithacidic acetone
followed by Pronasedigestionoftheprecipitatedglobin. Thedigest wasap-
plied toaboronate affinitycolumn, andthebound material waseluted with
pH 3 formatebuffer. Uppertracerecordedat343 nmandlowertraceat300
nm.
Thechromatogram illustrated inFigure 1 wasrecordedusing
adiodearrayUV/visibledetector, andthusspectrawereobtained
foreachpeak. Mostwereuninteresting, butfourofthemstrongly
resemble spectraofpolynucleararomatic systems (Fig. 2). Two
ofthepeaks areclearly apairofisomersexhibitingslightpertur-
bations of the spectrum of what is essentially the same
chromophore in each.
To be sure, thechromatographic and spectral evidence is in-
sufficient to identify the four peaks described above as PAH-
globin adducts. Nonetheless, these four compounds are suffi-
ciently likewhatcouldbeexpectedofsuchadductsthatthey war-
rant further efforts at identification.
CharacterizationofAdductsin Situ. Asindicatedabove, the
process ofbreaking downanadductedproteinintofragmentsof
molecularweightsuitableformostqualitativeanalyticaltechni-
ques may result in the loss ofparticularly labile adducts. Ifthe
carcinogen possesses achromophore, though, itmay bepossi-
ble to obtain structural information directly by spectroscopic
means. Fluorescence line narrowing (FLN) spectroscopy has
been used, forexample, toverify theexistence BPDE esterad-
ducts in both hemoglobin (24) and serum albumin (25).
Fluorescence linenarrowing produces spectrathatarehighly
distinctive. In the case ofBPDE adducts, the spectra are suffi-
ciently characteristic of the substituent present at C-10 that
hydroxy andalkoxy, carboxy, alkylamino, imidazolyl, andthioe-
theradductscanallbedistinguishedfromoneanother. Normal
humanhemoglobin, when subjected to FLN, exhibited a spec-
trum characteristic ofaC-10carboxy substituent, consistentwith
theknown presenceofesteradducts. Incontrast, human serum
albuminalkylated withBPDEwasmorecomplex, butcouldbe
deconvoluted to reveal the spectra of ester and imidazolyl
adducts.
The Binding Site AsaRegion ofa Protein
Toolittleisknownaboutthepropertiesofthebinding sitesof
proteins suchas serumalbuminorhemoglobintoallowmuchin
the way of generalities to be drawn at present. However, the
resultsobtained fromthestudyofcarcinogenbindingthusfarin-
dicate that considerable caution should be exercised in ex-
trapolating fromonecasetoanother. Forexample, itwasrecently
shown (21)thatanti-BPDE reactswithhumanserumalbuminto
formanadductatHis-146. Thisaminoacid isareactive residue
inapreviouslydescribedbinding siteforavarietyofhydrophobic
compoundslocated insubdomain 1-C(26). Ratserumalbumin
alsopossessesthishistidine residue, yetinarecent study (Tan-
nenbaumetal., unpublisheddata), wefoundthatitdoesnotreact
with fluoranthene diol epoxides. Instead, alysineadductispro-
duced, formedby reactionwith Lys-385, which resides in sub-
domain 2-C. Because this lysine is replaced by glutamine in
humanserumalbumin, itisnotpossibletomakeadefinitivecon-
clusion fromthese two results.
Ifthesubdomain 1-Cbinding siteistheprimarybinding site,
ashasbeensuggested (26), thentherewouldappeartobelimited
substrate specificity because fluoranthene did not react with
His-146. Alternatively, ourdatadonotcontradicttheconceptof
a more general subdomain 2-C binding site because human
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serum albumindoes nothave a lysineat residue 385, but ifthis
isthecase, thenonceagain it isevidentthatspeciesdifferences
mustbeclearly recognizedwhenusinganimal modelsforhuman
protein binding.
Conclusion
Carcinogen-protein adductshavebeenshownoverthepast 15
years to be useful biomarkers in a variety of biomonitoring
studies, especially as applied to the study ofknown or selected
chemicals. Furtheradvances inthe fieldmay includetheanalysis
of proteins to identify additional generically similar adducts,
thereby revealing previously undetermined exposures and veri-
fyingorrejectingtheparticipationofcertainmetabolicpathways
incarcinogenmetabolism. Amongthefactorsthatmaymakethis
possible is our increasing understanding ofthebinding sites of
proteins for the electrophilic intermediates produced by the
metabolism ofprocarcinogens.
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